Person:
UZUNER, ARZU

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

UZUNER

First Name

ARZU

Name

Filters

20222
Reset filters

Settings

Has files: true × Subject: CLINICAL MEDICINE ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationOpen Access
    The relationship between abdominal obesity and irritable bowel syndrome in adults
    (2022-01-01) UZUNER, ARZU; Doğan Kaya Y., Uzuner A.
    ABSTRACTObjective: The aim of this study is to evaluate the relationship between irritable bowel syndrome (IBS) and abdominal obesity.Patients and Methods: This is a cross-sectional study, consisting of 18-49 year old patients who applied to Marmara University Schoolof Medicine’s Family Medicine outpatient clinics and who accepted to participate. A questionnaire was applied using face-to-faceinterview technique; anthropometric measurements were obtained as recommended by World Health Organization (WHO). Thediagnosis of IBS was made for those who fully met the diagnostic criteria of ROME IV-IBS and had no alarm symptoms. Abdominalobesity of the participants was determined via anthropometric measurements. Statistical analyses were performed by using SPSS 20package program.Results: A total of 487 patients participated in the study: 77% female, 33% male; mean age value 33.71±8.59 years. The prevalenceof IBS was 24.2% (n=118) [F:27.2% (n=102), M:14.3% (n=16)]. Abdominal obesity prevalence was 31.2% (n=152) [F:24.5% (n=92,M:53.6% (n=60)]. There is no statistically significant difference in terms of abdominal obesity with and without IBS (p>0.05).Conclusion: In this study no statistically significant relationship has been detected between IBS and abdominal obesity.Keywords: Irritable bowel syndrome, Abdominal obesity, Central obesity
  • Thumbnail Image
    PublicationOpen Access
    Effect of eTansiyon smartphone application on hypertension control
    (2022-10-01) YILMAZ, EMRE; UZUNER, ARZU; DOĞAN, BUKET; ALTIKARDEŞ, ZEHRA AYSUN; AKDENİZ, ESRA; YILMAZ E., UZUNER A., Bajgora M., DOĞAN B., ALTIKARDEŞ Z. A. , Geris B. K. , AKDENİZ E.
    Aim: To investigate the effectiveness of eTansiyon smartphone application in blood pressure control in patients with hypertension. Background: Global prevalence of hypertension and the burden of chronic illness care, especially in primary care, are increasing in world. We have developed eTansiyon to ensure the continuity of patient-physician relationship, so it may help to improve the lifestyle of patients with hypertension, increase their adherence to treatment and achieve the target blood pressure. Methods: This study was a non-randomized controlled study. The sample was selected by random sampling method among the patients registered in 6 Family Health Units (FHUs). Randomization was performed at the FHU level; the units were randomized to 4 control group (CG) and 2 intervention group (IG), so that randomization in this study was 2:1. Both groups were followed up for at least four months. In addition to CG, IG were provided to use eTansiyon. Obtained data were analysed to evaluate differences between groups at the beginning and end of the study, intra-group changes after follow-up and interaction between groups and follow-up period. Findings: The study was performed with 124 patients in CG and 61 patients in IG. At the end of the study, the average systolic blood pressure/diastolic blood pressure (SBP/DBP) of office and home was significantly lower in IG compared to CG (P < 0.001, MD 9.5 mmHg; P = 0.007, MD 3.8 mmHg; P < 0.001, MD 10.6 mmHg; P < 0.001, MD 4.8 mmHg, respectively), and it was found that the proportion of people with target blood pressure in IG was significantly higher than CG (P < 0.001, 49.2%(n = 30) and 22.6%(n = 28), respectively). Repeated measures ANOVA and generalized estimating equations results showed that follow-up period and interaction between groups were significant in terms of office and home SBP/DBP and target blood pressure level during follow-up period (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.024, respectively).